Exact Mass: 596.2750199999999
Exact Mass Matches: 596.2750199999999
Found 417 metabolites which its exact mass value is equals to given mass value 596.2750199999999
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Magnoline
Salannin
Salannin is a limonoid with insecticidal activity isolated from Azadirachta indica. It has a role as an insect growth regulator, an antifeedant and a plant metabolite. It is an acetate ester, a member of furans, a limonoid, an organic heteropentacyclic compound and a methyl ester. It is functionally related to a tiglic acid. Salannin is a natural product found in Azadirachta indica, Melia azedarach, and other organisms with data available. A limonoid with insecticidal activity isolated from Azadirachta indica.
Guattegaumerine
An aromatic ether resulting from oxidative dimerisation between the 4-hydroxy group of one molecule of (1R)-1-(4-hydroxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol and the 3-position of the 4-hydroxybenzyl group of another.
Dipiperamide D
Dipiperamide D is an alkaloid from white pepper, Piper nigrum. Alkaloid from white pepper, Piper nigrum
Pipercyclobutanamide B
Pipercyclobutanamide B is found in herbs and spices. Pipercyclobutanamide B is an alkaloid from the fruit of Piper nigrum (pepper Alkaloid from the fruit of Piper nigrum (pepper). Pipercyclobutanamide B is found in herbs and spices.
Tetragastrin
Tetragastrin is the C-terminal tetrapeptide of gastrin. It is the smallest peptide fragment of gastrin which has the same physiological and pharmacological activity as gastrin. [HMDB] Tetragastrin is the C-terminal tetrapeptide of gastrin. It is the smallest peptide fragment of gastrin which has the same physiological and pharmacological activity as gastrin. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005755 - Gastrins Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate gastric secretion[1]. Tetragastrin is a Cholecystokinin (CCK-4) receptor agonist[2]. Gastric mucosal protection[3]. Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate gastric secretion[1]. Tetragastrin is a Cholecystokinin (CCK-4) receptor agonist[2]. Gastric mucosal protection[3].
Chlorin E6
Chlorin E6 (chlorin(e6)) is a photosensitizer used in photodynamic therapy. Photodynamic therapy (PDT) is a form of phototherapy using nontoxic light-sensitive compounds that are exposed selectively to light, whereupon they become toxic to targeted malignant and other diseased cells. PDT has proven ability to kill microbial cells including bacteria, fungi and viruses. PDT is popularly used in treating acne. It is used clinically to treat a wide range of medical conditions, including wet age-related macular degeneration and malignant cancers, and is recognised as a treatment strategy which is both minimally invasive and minimally toxic. A photosensitizer is a chemical compound that can be promoted to an excited state upon absorption light and undergo intersystem crossing with oxygen to produce singlet oxygen. This species rapidly attacks any organic compounds it encounters, thus being highly cytotoxic. A wide array of photosensitizers for PDT exist. They can be divided into porphyrins, chlorophylls and dyes. Some examples include aminolevulinic acid (ALA), Silicon Phthalocyanine Pc 4, m-tetrahydroxyphenylchlorin (mTHPC), and mono-L-aspartyl chlorin e6 (NPe6). (Wikipedia)
LysoPI(18:2(9Z,12Z)/0:0)
LysoPI(18:2(9Z,12Z)/0:0) is a lysophosphatidylinositol. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylinositols can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPI(18:2(9Z,12Z)/0:0), in particular, consists of one chain of linoleic acid at the C-1 position.
(2R)-2-Hydroxy-3-[(hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl)oxy]propyl (9Z,12Z)-octadeca-9,12-dienoate
GDC-0834 Racemate
Salannin
(7S*,8R*,7S*,8R*)-4,4-dimethoxyhuazhongilexin 9-O-alpha-L-arabinopyranoside
3-hydroxy-4,5-dimethoxyphenyl 6-O-{(2E,4E)-5-[(1R,3S,5R,8S)-3,8-dihydroxy-1,5-dimethyl-6-oxabixyclo[3.2.1.]oct-8-yl]-3-methyl-1-oxopenta-2,4-dien-1-yl}-alpha-L-glucopyranoside|thorelinin
Thollosidsaeure-methylester|Thollosidsaeuremethylester; 3beta-(alpha-L-Rhamnosido-(1,5))-sarmentosigenin-A-saeuremethylester; 3beta-(alpha-L-Rhamnosido-(1,5))-5,11alpha,14beta-trihydroxy-5beta-cardenolid-19-saeuremethylester|Thollosidsaeuremethylester; 3beta--sarmentosigenin-A-saeuremethylester; 3beta--5,11alpha,14beta-trihydroxy-5beta-cardenolid-19-saeuremethylester
16-O-deca-2,4,6-trienoyl-13,20-diacetyl-12-deoxyphorbol
(+)-4-O-methyllyoniresin-4-yl beta-D-glucopyranoside
(15S)-15-ethoxy-14,15-dihydroajugapitin|15-ethoxy-14-hydroajugapitin|15alpha-ethoxy-14-hydroajugapitin
Hexa-Me ether-(R)-2,4,7-Trihydroxy-3-(2,4,7-trihydroxyisoflavan-6-yl)flav-2-ene
5beta-acetoxy-4beta,10-diangeloyloxy-3beta-isobutyryloxy-2beta,8,11-trihydroxy-bisabol-7(14)-ene
3,7,15-O-triacetyl-5-O-benzoyl-13,17-oxy-14-oxopremyrsinol
C33H40O10_1H-Cyclopentacyclododecene-4,10(2H,5H)-dione, 3a,9,13-tris(acetyloxy)-1-(benzoyloxy)-3,3a,8,9,13,13a-hexahydro-2,5,8,8,12-pentamethyl-, (6E,11E)
Cys Arg Arg Tyr
Cys Arg Tyr Arg
Cys Tyr Arg Arg
Glu His Arg Arg
Glu Arg His Arg
Glu Arg Arg His
Phe Phe Phe His
Phe Phe His Phe
Phe Phe Gln Arg
C29H40N8O6 (596.3070660000001)
Phe Phe Arg Gln
C29H40N8O6 (596.3070660000001)
Phe His Phe Phe
Phe His Met Tyr
Phe His Tyr Met
Phe Met His Tyr
Phe Met Asn Trp
Phe Met Trp Asn
Phe Met Tyr His
Phe Asn Met Trp
Phe Asn Trp Met
Phe Gln Phe Arg
C29H40N8O6 (596.3070660000001)
Phe Gln Arg Phe
C29H40N8O6 (596.3070660000001)
Phe Arg Phe Gln
C29H40N8O6 (596.3070660000001)
Phe Arg Gln Phe
C29H40N8O6 (596.3070660000001)
Phe Trp Met Asn
Phe Trp Asn Met
Phe Tyr His Met
Phe Tyr Met His
His Glu Arg Arg
His Phe Phe Phe
His Phe Met Tyr
His Phe Tyr Met
His Met Phe Tyr
His Met Tyr Phe
His Arg Glu Arg
His Arg Arg Glu
His Arg Val Trp
His Arg Trp Val
His Val Arg Trp
His Val Trp Arg
His Trp Arg Val
His Trp Val Arg
His Tyr Phe Met
His Tyr Met Phe
Lys Met Arg Tyr
C26H44N8O6S (596.3104364000001)
Lys Met Tyr Arg
C26H44N8O6S (596.3104364000001)
Lys Arg Met Tyr
C26H44N8O6S (596.3104364000001)
Lys Arg Tyr Met
C26H44N8O6S (596.3104364000001)
Lys Thr Trp Tyr
Lys Thr Tyr Trp
Lys Trp Thr Tyr
Lys Trp Tyr Thr
Lys Tyr Met Arg
C26H44N8O6S (596.3104364000001)
Lys Tyr Arg Met
C26H44N8O6S (596.3104364000001)
Lys Tyr Thr Trp
Lys Tyr Trp Thr
Met Phe His Tyr
Met Phe Asn Trp
Met Phe Trp Asn
Met Phe Tyr His
Met His Phe Tyr
Met His Tyr Phe
Met Lys Arg Tyr
C26H44N8O6S (596.3104364000001)
Met Lys Tyr Arg
C26H44N8O6S (596.3104364000001)
Met Asn Phe Trp
Met Asn Trp Phe
Met Gln Arg Tyr
C25H40N8O7S (596.2740530000001)
Met Gln Tyr Arg
C25H40N8O7S (596.2740530000001)
Met Arg Lys Tyr
C26H44N8O6S (596.3104364000001)
Met Arg Gln Tyr
C25H40N8O7S (596.2740530000001)
Met Arg Tyr Lys
C26H44N8O6S (596.3104364000001)
Met Arg Tyr Gln
C25H40N8O7S (596.2740530000001)
Met Trp Phe Asn
Met Trp Asn Phe
Met Tyr Phe His
Met Tyr His Phe
Met Tyr Lys Arg
C26H44N8O6S (596.3104364000001)
Met Tyr Gln Arg
C25H40N8O7S (596.2740530000001)
Met Tyr Arg Lys
C26H44N8O6S (596.3104364000001)
Met Tyr Arg Gln
C25H40N8O7S (596.2740530000001)
Asn Phe Met Trp
Asn Phe Trp Met
Asn Met Phe Trp
Asn Met Trp Phe
Asn Trp Phe Met
Asn Trp Met Phe
Gln Phe Phe Arg
C29H40N8O6 (596.3070660000001)
Gln Phe Arg Phe
C29H40N8O6 (596.3070660000001)
Gln Met Arg Tyr
C25H40N8O7S (596.2740530000001)
Gln Met Tyr Arg
C25H40N8O7S (596.2740530000001)
Gln Arg Phe Phe
C29H40N8O6 (596.3070660000001)
Gln Arg Met Tyr
C25H40N8O7S (596.2740530000001)
Gln Arg Tyr Met
C25H40N8O7S (596.2740530000001)
Gln Thr Trp Tyr
Gln Thr Tyr Trp
Gln Trp Thr Tyr
Gln Trp Tyr Thr
Gln Tyr Met Arg
C25H40N8O7S (596.2740530000001)
Gln Tyr Arg Met
C25H40N8O7S (596.2740530000001)
Gln Tyr Thr Trp
Gln Tyr Trp Thr
Arg Cys Arg Tyr
Arg Cys Tyr Arg
Arg Glu His Arg
Arg Glu Arg His
Arg Phe Phe Gln
C29H40N8O6 (596.3070660000001)
Arg Phe Gln Phe
C29H40N8O6 (596.3070660000001)
Arg His Glu Arg
Arg His Arg Glu
Arg His Val Trp
Arg His Trp Val
Arg Lys Met Tyr
C26H44N8O6S (596.3104364000001)
Arg Lys Tyr Met
C26H44N8O6S (596.3104364000001)
Arg Met Lys Tyr
C26H44N8O6S (596.3104364000001)
Arg Met Gln Tyr
C25H40N8O7S (596.2740530000001)
Arg Met Tyr Lys
C26H44N8O6S (596.3104364000001)
Arg Met Tyr Gln
C25H40N8O7S (596.2740530000001)
Arg Gln Phe Phe
C29H40N8O6 (596.3070660000001)
Arg Gln Met Tyr
C25H40N8O7S (596.2740530000001)
Arg Gln Tyr Met
C25H40N8O7S (596.2740530000001)
Arg Arg Cys Tyr
Arg Arg Glu His
Arg Arg His Glu
Arg Arg Tyr Cys
Arg Val His Trp
Arg Val Trp His
Arg Trp His Val
Arg Trp Val His
Arg Tyr Cys Arg
Arg Tyr Lys Met
C26H44N8O6S (596.3104364000001)
Arg Tyr Met Lys
C26H44N8O6S (596.3104364000001)
Arg Tyr Met Gln
C25H40N8O7S (596.2740530000001)
Arg Tyr Gln Met
C25H40N8O7S (596.2740530000001)
Arg Tyr Arg Cys
Thr Lys Trp Tyr
Thr Lys Tyr Trp
Thr Gln Trp Tyr
Thr Gln Tyr Trp
Thr Trp Lys Tyr
Thr Trp Gln Tyr
Thr Trp Tyr Lys
Thr Trp Tyr Gln
Thr Tyr Lys Trp
Thr Tyr Gln Trp
Thr Tyr Trp Lys
Thr Tyr Trp Gln
Val His Arg Trp
Val His Trp Arg
Val Arg His Trp
Val Arg Trp His
Val Trp His Arg
Val Trp Arg His
Trp Phe Met Asn
Trp Phe Asn Met
Trp His Arg Val
Trp His Val Arg
Trp Lys Thr Tyr
Trp Lys Tyr Thr
Trp Met Phe Asn
Trp Met Asn Phe
Trp Asn Phe Met
Trp Asn Met Phe
Trp Gln Thr Tyr
Trp Gln Tyr Thr
Trp Arg His Val
Trp Arg Val His
Trp Thr Lys Tyr
Trp Thr Gln Tyr
Trp Thr Tyr Lys
Trp Thr Tyr Gln
Trp Val His Arg
Trp Val Arg His
Trp Tyr Lys Thr
Trp Tyr Gln Thr
Trp Tyr Thr Lys
Trp Tyr Thr Gln
Tyr Cys Arg Arg
Tyr Phe His Met
Tyr Phe Met His
Tyr His Phe Met
Tyr His Met Phe
Tyr Lys Met Arg
C26H44N8O6S (596.3104364000001)
Tyr Lys Arg Met
C26H44N8O6S (596.3104364000001)
Tyr Lys Thr Trp
Tyr Lys Trp Thr
Tyr Met Phe His
Tyr Met His Phe
Tyr Met Lys Arg
C26H44N8O6S (596.3104364000001)
Tyr Met Gln Arg
C25H40N8O7S (596.2740530000001)
Tyr Met Arg Lys
C26H44N8O6S (596.3104364000001)
Tyr Met Arg Gln
C25H40N8O7S (596.2740530000001)
Tyr Gln Met Arg
C25H40N8O7S (596.2740530000001)
Tyr Gln Arg Met
C25H40N8O7S (596.2740530000001)
Tyr Gln Thr Trp
Tyr Gln Trp Thr
Tyr Arg Cys Arg
Tyr Arg Lys Met
C26H44N8O6S (596.3104364000001)
Tyr Arg Met Lys
C26H44N8O6S (596.3104364000001)
Tyr Arg Met Gln
C25H40N8O7S (596.2740530000001)
Tyr Arg Gln Met
C25H40N8O7S (596.2740530000001)
Tyr Arg Arg Cys
Tyr Thr Lys Trp
Tyr Thr Gln Trp
Tyr Thr Trp Lys
Tyr Thr Trp Gln
Tyr Trp Lys Thr
Tyr Trp Gln Thr
Tyr Trp Thr Lys
Tyr Trp Thr Gln
CCK-4
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005755 - Gastrins Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate gastric secretion[1]. Tetragastrin is a Cholecystokinin (CCK-4) receptor agonist[2]. Gastric mucosal protection[3]. Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate gastric secretion[1]. Tetragastrin is a Cholecystokinin (CCK-4) receptor agonist[2]. Gastric mucosal protection[3].
(5b,7a,12a)-(1,3-dihydro-5-nitro-1,3-dioxo-2H-isoindol-2-yl)methyl ester
Pipercyclobutanamide B
Dipiperamide D
Chlorin E6
D011838 - Radiation-Sensitizing Agents
Trimetaphan camsylate
C32H40N2O5S2 (596.2378510000001)
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Phenolphthalein monophosphate dicyclohexylammonium salt
4-Methoxyphenyl 2,4,6-tris-O-(phenylmethyl)-3-O-2-propen-1-yl-beta-D-galactopyranoside
H-Tyr-Arg-Gly-Asp-Ser-OH trifluoroacetate salt
YRGDS Fibronectin Fragment is a fibronectin fragment, an adhesion peptide that displays strong binding affinity to thrombin-stimulated platelets[1].
(2S)-3-(4-(4-Carbamoylpiperidine-1-carbonyl)oxyphenyl)-2-(((2S)-4-methyl-2-((2-(2-methylphenoxy)acetyl)amino)pentanoyl)amino)propanoic acid
C31H40N4O8 (596.2846000000001)
haematoporphyrin IX
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents > D006415 - Hematoporphyrins D003879 - Dermatologic Agents
3-[(17S,18R)-18-(2-carboxyethyl)-7,12-bis(ethenyl)-17,18-dihydroxy-3,8,13,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid
3-[(21S,22S)-11,26-diethyl-4-hydroxy-16-[(1R)-1-hydroxyethyl]-12-(hydroxymethyl)-17,19,21-trimethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid
3-[(17R,18R)-18-(2-carboxyethyl)-7,12-bis(ethenyl)-17,18-dihydroxy-3,8,13,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid
[14-acetyloxy-6-(furan-3-yl)-10-(2-methoxy-2-oxoethyl)-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.02,9.04,8.015,18]octadec-7-en-12-yl] (E)-2-methylbut-2-enoate
Trimethaphan Camsylate
C32H40N2O5S2 (596.2378510000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Lys-Thr-Trp-Tyr
A tetrapeptide composed of L-lysine, L-threonine, L-tryptophan and L-tyrosine joined in sequence by peptide linkages.
1-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
[(6E,11E)-3a,9,13-triacetyloxy-2,5,8,8,12-pentamethyl-4,10-dioxo-2,3,5,9,13,13a-hexahydro-1H-cyclopenta[12]annulen-1-yl] benzoate
[(4R,5R)-4-[[2-(azidomethyl)phenyl]methyl]-5-(2-azidophenyl)-2-[4-(3-hydroxypropoxy)phenyl]-5H-oxazol-4-yl]-(4-morpholinyl)methanone
C31H32N8O5 (596.2495541999999)
1-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
(4R,7S,8R)-N-(3,5-dimethyl-4-isoxazolyl)-14-[[(3-fluoroanilino)-oxomethyl]amino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(3R)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-4-[3-(3-hydroxy-3-methylbut-1-ynyl)phenyl]-N-[3-(4-morpholinyl)propyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
(4S,7R,8R)-N-(3,5-dimethyl-1,2-oxazol-4-yl)-14-[(3-fluorophenyl)carbamoylamino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7S,8R)-N-(3,5-dimethyl-1,2-oxazol-4-yl)-14-[(3-fluorophenyl)carbamoylamino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7S,8S)-N-(3,5-dimethyl-1,2-oxazol-4-yl)-14-[(3-fluorophenyl)carbamoylamino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
N-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide
C32H44N4O7 (596.3209833999999)
(4R,7S,8S)-N-(3,5-dimethyl-4-isoxazolyl)-14-[[(3-fluoroanilino)-oxomethyl]amino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
N-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide
C32H44N4O7 (596.3209833999999)
N-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide
C32H44N4O7 (596.3209833999999)
N-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide
C32H44N4O7 (596.3209833999999)
N-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide
C32H44N4O7 (596.3209833999999)
N-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide
C32H44N4O7 (596.3209833999999)
N-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide
C32H44N4O7 (596.3209833999999)
(4R,7R,8S)-N-(3,5-dimethyl-4-isoxazolyl)-14-[[(3-fluoroanilino)-oxomethyl]amino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4R,7R,8R)-N-(3,5-dimethyl-4-isoxazolyl)-14-[[(3-fluoroanilino)-oxomethyl]amino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7R,8S)-N-(3,5-dimethyl-4-isoxazolyl)-14-[[(3-fluoroanilino)-oxomethyl]amino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
3-[(17S,18R)-18-(2-carboxyethyl)-8,13-bis(ethenyl)-17,18-dihydroxy-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid
3-[(17R,18R)-18-(2-carboxyethyl)-8,13-bis(ethenyl)-17,18-dihydroxy-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid
[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (9Z,12Z)-octadeca-9,12-dienoate
[(11Z)-3a,9,13-triacetyloxy-2,5,8,8,12-pentamethyl-4,10-dioxo-2,3,5,9,13,13a-hexahydro-1H-cyclopenta[12]annulen-1-yl] benzoate
[(1R,2S,4R,6R,9R,10S,11R,12S,14R,15R,18R)-14-Acetyloxy-6-(furan-3-yl)-10-(2-methoxy-2-oxoethyl)-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.02,9.04,8.015,18]octadec-7-en-12-yl] (E)-2-methylbut-2-enoate
(2R)-2-Hydroxy-3-[(hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl)oxy]propyl (9Z,12Z)-octadeca-9,12-dienoate
Tetragastrin
A tetrapeptide composed of L-tryptophan, L-methione, L-aspartic acid and L-phenylalaninamide residues joined in sequence.